Mbx Biosciences, Inc. · NASDAQ:MBX
Wellington Biomedical Innovation Master Investors (Cayman) II, L.P.'s stake in Mbx Biosciences, Inc. fell to 4.50% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 12, 2025
Wellington Biomedical Innovation Master Investors (Cayman) II, L.P.'s stake in Mbx Biosciences, Inc. fell to 4.50%, 2,017,394 shares, as a passive investor on Sep 30, 2025. Filed Nov 12, 2025 (Schedule 13G/A).
- Stake
- 4.50%
- Shares
- 2,017,394
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. | 4.50% | 2,017,394 |
Source
Related
- Mbx Biosciences, Inc.
- Wellington Biomedical Innovation Master Investors (Cayman) II, L.P.
- Mbx Biosciences, Inc. shareholders
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026
- Schedule 13D/A · James N. Topper · Aug 10, 2026
- Schedule 13D/A · Orbimed Advisors LLC · Aug 10, 2026
- Form 4 · Azoulay Salomon · Aug 5, 2026
- Form 4 · Smither John W · Aug 4, 2026